Invest via Card/BankInvest via Crypto

Autonomyo

Revolutionizing Neurological Rehabilitation

MECHANICS
MEDICAL DEVICES
ROBOTICS
MEDTECH
REHAB
AI
No items found.

Highlights

  • Wearable exoskeleton for rehabilitation training for neurological conditions
  • Over 15 million stroke patients globally each year
  • Autonomyo's home rehabilitation solution is 10x cheaper than traditional therapy in clinics
  • Wearable exoskeleton provides personalized and adaptive support for movements
  • CHF100 Bn addressable market for physical rehabilitation products and services
  • Autonomyo has secured a total of CHF1M funding since incorporation

Problem

Challenges in Neurological Rehabilitation

The field of neurological rehabilitation faces significant challenges that hinder the recovery and independence of millions of individuals worldwide.

One pressing problem lies in the aftermath of strokes:

  • 15 million stroke patients globally per year
  • One in four individuals will experience a stroke in their lifetime
  • 50-60% of stroke survivors are discharged with major disabilities

The current approach, predominantly focused on costly inpatient stays, falls short in meeting the long-term needs of patients.

Solution

A Cost-Effective Wearable Exoskeleton

Our solution focuses on leveraging wearable exoskeleton technology, specifically designed for use by non-professional users, to facilitate home rehabilitation.

Our solution:

  • An innovative approach: it combines intensive training starting during the inpatient stay with continued rehabilitation at home
  • A cost-effective solution: allowing daily training for patients could change the game and largely impact the level of disability among neurological patients.

This not only empowers patients but also enables physical therapists to remotely monitor their progress and provide AI-based training solutions. By making home rehabilitation accessible to everyone in need, we aim to revolutionize the field of neurological rehabilitation.

Product

The wearable exoskeleton offers personalized and adaptive support for movements

Allowing individuals to regain autonomy and enhance their motor abilities.

The digital platform complements the exoskeleton with personalized training plans, gamification elements, and remote support from physiotherapy professionals.

With a focus on cost-effective and prolonged therapy at home, Autonomyo aims to reduce disabilities and improve the quality of life for individuals with neurological conditions.

Through data-driven optimization, the platform continuously improves therapy plans, leading to better outcomes for patients.

Customers

Business Model

Market Opportunity

Traction

Competition

Roadmap

Vision & Strategy

Use of Funds

Summary

Team

Closed

00
Days
00
Hrs
00
Min
00
Sec

Pre-registered sale

80%

CHF 107'387.63
Public Sale Phase
55
Number of Investors
CHF 0.29 (~ $0.32)
Price per Share
Invest via Card/BankInvest via Crypto
Minimum investment CHF 100
I am interested

Deal Terms

Minimum Investment
Valuation
Type of Investment

Company info

Headquarter
Lausanne
Incorporation
March 2021
LinkedIn
// Countdown